Anaheim Bio
Anaheim Bio is a biotech company in Leiden, Netherlands. It has 1 recorded funding round, most recently a Series A in November 2026.
Small by Design. Big on Impact.
- Headquarters
- Leiden
- Website
- anaheimbio.com
- Last Round
- Series ANov 2026
- Rounds
- 1
Indexed holds 1 funding round for this company. The full record is or through the API.
About
Anaheim Bio is a biotech company developing a small-molecule therapy for calcium pyrophosphate deposition disease (CPPD), a crystal-induced arthritis in which calcium pyrophosphate crystals form in the joint and trigger painful inflammation. Its lead program, ANA-1, lowers pyrophosphate in the joint to limit crystal formation, aiming to be the first disease-modifying therapy for CPPD with a measurable biomarker. The company describes CPPD as a common, painful disease with no therapy that treats its cause, and says it mostly affects adults over 60.
Summary
Its most recent funding was a Series A round in Nov 2026.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2026
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/anaheim-bio"><img src="https://indexed.vc/api/badge/company/anaheim-bio" alt="Anaheim Bio on Indexed.vc" width="260" height="76" /></a>